MediClin AG (XTER:MED) 5-Year Yield-on-Cost %: 0.97 (As of Jul. 31, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:MED MediClin AG XTER:MED
78 GF Score
Price €4.10
GF Value €3.03
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is MediClin AG 5-Year Yield-on-Cost %?

MediClin AG XTER:MED -0.97% 78 5-Year Yield-on-Cost % is 0.97 as of Jul. 31, 2026, which is 1% above its 10-year median of 0.96. GuruFocus rates XTER:MED with a GF Score™ of 78/100 and a GF Value™ of €3.03 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 275 Healthcare Providers & Services companies, MediClin AG ranks worse than 79.27% on this metric.

MediClin AG's yield on cost for the quarter that ended in Mar. 2026 was 0.97.


The historical rank and industry rank for MediClin AG's 5-Year Yield-on-Cost % or its related term are showing as below:

XTER:MED' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.81   Med: 0.96   Max: 1.37
Current: 0.97


During the past 13 years, MediClin AG's highest Yield on Cost was 1.37. The lowest was 0.81. And the median was 0.96.


XTER:MED's 5-Year Yield-on-Cost % is ranked worse than
79.27% of 275 companies
in the Healthcare Providers & Services industry
Industry Median: 2.93 vs XTER:MED: 0.97

MediClin AG  (XTER:MED) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


MediClin AG 5-Year Yield-on-Cost % Related Terms


XTER:MED vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison

For the Medical Care Facilities subindustry, MediClin AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediClin AG 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where MediClin AG's 5-Year Yield-on-Cost % falls into.


XTER:MED
78GF Score
MediClin AG XTER:MED
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediClin AG 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of MediClin AG is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.97 mean?
MediClin AG (XTER:MED) has a 5-Year Yield-on-Cost % of 0.97 as of Jul. 31, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on MediClin AG and its competitors. This is near median its historical median of 0.96. Over the past decade, MediClin AG's 5-Year Yield-on-Cost % has ranged from 0.81 to 1.37. According to the industry distribution chart, MediClin AG ranks #218 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 79.3%.
Is MediClin AG's 5-Year Yield-on-Cost % too high?
MediClin AG's current 5-Year Yield-on-Cost % of 0.97 is near median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 1.37. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.93. MediClin AG's value of 0.97 is 66.9% below this industry median. Based on the distribution chart, MediClin AG ranks #218 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MediClin AG has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MediClin AG's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, MediClin AG ranks #218 out of 275 companies for 5-Year Yield-on-Cost %. This places MediClin AG in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. MediClin AG's value of 0.97 is 66.9% below this benchmark. Historically, MediClin AG's own 5-Year Yield-on-Cost % has ranged from 0.81 to 1.37 over the past decade. While the company's 10-year median is 0.96 vs. the industry median of 2.93, MediClin AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MediClin AG's current 5-Year Yield-on-Cost % of 0.97 is 66.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on MediClin AG and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MediClin AG's current 5-Year Yield-on-Cost % is 0.97, which is near median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediClin AG stock overvalued right now?
Based on GuruFocus' analysis, MediClin AG (XTER:MED) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.03, compared to a current price of €4.10 — trading 35.3% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.97, which is near median its 10-year median of 0.96 and 66.9% below the Healthcare Providers & Services industry median of 2.93. MediClin AG's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For MediClin AG (XTER:MED), the current 5-Year Yield-on-Cost % is 0.97 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MediClin AG (XTER:MED) Overvalued in 2026?

Based on GuruFocus' analysis, MediClin AG stock appears to be overvalued. The current stock price of €4.10 is trading 35.3% above its estimated GF Value™ of €3.03. GuruFocus considers MediClin AG to be Significantly Overvalued.

Key valuation signals for XTER:MED:

  • 5-Year Yield-on-Cost %: 0.97 (near median its 10-year median of 0.96)
  • GF Value™: €3.03 vs. price of €4.10 (35.3% above fair value)
  • GF Score™: 78/100 with 6 warning signs
  • Industry Position: 66.9% below the Healthcare Providers & Services median (#218 of 275)

No single metric tells the full story. See the XTER:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MediClin AG Business Description

Other Exchanges 0NDG:UK
Address Okenstrasse 27, Offenburg, BW, DEU, 77652
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
78GF Score

Get the complete analysis for XTER:MED

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.10
Price
€3.03
GF Value